TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 70 filers reported holding TRINITY BIOTECH PLC in Q3 2013. The put-call ratio across all filers is 0.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $11,281,000 | +10.5% | 853,345 | -5.2% | 1.03% | -0.5% |
| Q2 2016 | $10,206,000 | -2.7% | 900,000 | 0.0% | 1.03% | +4.4% |
| Q1 2016 | $10,494,000 | +61.8% | 900,000 | +63.2% | 0.99% | +41.1% |
| Q4 2015 | $6,487,000 | +1.8% | 551,632 | -1.0% | 0.70% | +20.5% |
| Q3 2015 | $6,373,000 | -54.1% | 557,117 | -27.6% | 0.58% | -55.0% |
| Q2 2015 | $13,891,000 | +7.2% | 769,165 | +14.3% | 1.29% | -31.7% |
| Q1 2015 | $12,957,000 | +11.9% | 673,079 | +1.8% | 1.89% | +2.9% |
| Q4 2014 | $11,579,000 | +5.5% | 661,261 | +10.1% | 1.84% | +13.1% |
| Q3 2014 | $10,976,000 | -8.5% | 600,770 | +15.4% | 1.62% | +3.7% |
| Q2 2014 | $11,993,000 | +2.4% | 520,770 | +7.8% | 1.56% | +17.5% |
| Q1 2014 | $11,709,000 | -8.4% | 483,263 | -4.9% | 1.33% | -17.7% |
| Q4 2013 | $12,778,000 | +21.5% | 508,263 | +5.2% | 1.62% | +3.9% |
| Q3 2013 | $10,518,000 | +39.2% | 483,355 | +7.8% | 1.56% | +74.7% |
| Q2 2013 | $7,556,000 | – | 448,415 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 873,594 | $4,455,000 | 2.19% |
| STONEHILL CAPITAL MANAGEMENT LLC | 738,829 | $3,768,000 | 1.54% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 1,026,624 | $5,236,000 | 1.43% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 711,185 | $3,627,000 | 1.34% |
| Lapides Asset Management, LLC | 1,173,400 | $5,984,000 | 1.30% |
| Adirondack Research & Management Inc. | 408,337 | $2,083,000 | 0.82% |
| Paradice Investment Management LLC | 1,639,296 | $8,360,000 | 0.61% |
| HEARTLAND ADVISORS INC | 1,346,150 | $6,865,000 | 0.44% |
| Senvest Management, LLC | 1,003,988 | $5,120,000 | 0.36% |
| Fondren Management LP | 100,000 | $510,000 | 0.36% |